Your browser is no longer supported. Please, upgrade your browser.
XBI  SPDR S&P Biotech ETF daily Stock Chart
SPDR S&P Biotech ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-1.85%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month2.47%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter12.33%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y32.80%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year58.95%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range132.76 - 261.60 Perf YTD32.80%
Dividend2.00 P/FCF- EPS past 5Y- ROI- 52W High-5.60% Beta-
Dividend %0.81% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low86.00% ATR6.49
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)54.99 Volatility3.26% 2.43%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.58 Prev Close249.22
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume1.09M Price246.94
Recom- SMA200.03% SMA505.17% SMA20022.58% Volume632,418 Change-0.91%
Jul-03-15 02:06AM  WEEKEND VIDEO: Sentiment, Stocks and more
Jun-23-15 09:00AM  Mess With the Leveraged Biotech Bull ETF and get the Horns
Jun-21-15 03:19PM  Weekend Market VIDEO: Apple, Stocks to Watch, and Biotech
Jun-15-15 02:13PM  Biotech's Rally Has Long-Term Legs, Asserts S&P Capital IQ Director at TheStreet
07:00AM  These ETFs Will Like the Bluebird Bio News
Jun-12-15 08:03AM  How bubbles are blown: Biotech edition (Exhibit III)
Jun-11-15 09:30PM  The scariest investment trend of the next century
Jun-10-15 06:39PM  Can Health Care ETFs Keep Beating The Stock Market? at Investor's Business Daily
12:24PM  4 Sector ETFs Outperforming in 2015 - ETF News And Commentary
Jun-09-15 09:46AM  The Only Way to Play Biotech Buyouts
08:00AM  Two Big Biotech ETFs
Jun-03-15 11:30AM  A New Biotech ETF Could Challenge Established Rivals
Jun-02-15 08:00AM  New Leveraged Biotech ETF off to a Fast Start
Jun-01-15 03:25PM  Record Margin Debt: Tailwind Or Bubble?
May-28-15 11:47AM  Back in the Lab: Triple-Leveraged Biotech ETFs are Here
May-27-15 08:49PM  ETFs Top Mutual Funds In Popularity With Financial Advisors at Investor's Business Daily
May-21-15 06:21PM  Your first trade for Friday at CNBC
05:58PM  Final Trade: CHL, GPRO, XBI, & URBN
May-20-15 04:25PM  'Don't Give Up On Biotech Yet,' Says This CFA
01:02PM  Heres your only safe bet in this sickly stock market at MarketWatch
May-19-15 06:54PM  China ETFs Power Ahead In 2015; Gold, Silver Get Shine Back at Investor's Business Daily
06:37PM  Your first trade for Wednesday at CNBC
May-15-15 05:15PM  Biotech movers: JNJ & BLUE
May-11-15 10:27PM  How to plan your next conviction trade
May-07-15 05:35PM  Pisani: Markets shrug at big week of biotech IPOs at CNBC
May-06-15 05:10PM  Biotech Sector: Support Levels To Watch
01:00PM  More Biotech Deal-Making Lifts a few ETFs
May-05-15 05:58PM  Its time to start talking about a biotech correction
May-04-15 06:14PM  Your first trade for Tuesday, May 5 at CNBC
May-03-15 06:09PM  The Best (And Worst) ETFs Of Last Week Amid Social Media's Collapse
Apr-30-15 10:44PM  Busted biotechs: by the numbers
11:22AM  No Pain, No Gain
Apr-28-15 02:45PM  A Tough Spot for Biotech ETFs
07:28AM  Bio-Techs under Pressure (Again) Try the Swordfish - Palermo Style
Apr-27-15 03:32PM  What's wrong with healthcare and biotech at CNBC -5.52%
Apr-21-15 11:35AM  Will Amgen Earnings Shape Biotech for the Rest of 2015? at 24/7 Wall St.
08:20AM  Biotech ETF Run not Over Yet, Says Analyst
Apr-07-15 02:00PM  Halftime's hottest trades today: BTU, FB, JPM & XBI
12:58PM  Top trades for the 2nd half: AA, XBI, VLO & WTI
11:10AM  Bio Tech- Support test in play after large reversal pattern
Apr-03-15 03:06PM  How Actavis Generics Drive Revenues
Apr-02-15 10:00AM  Dyax HAE Drug Result Fuels Three Biotech ETFs - ETF News And Commentary
Apr-01-15 02:24PM  Don't get duped: April Fools' Day trades to go at CNBC
01:50PM  This Sector Is Dominating The IPO Market In 2015
12:58PM  April Fools' trades: Shake Shack, Delta & more
11:40AM  Cashin says: Unidentified trade takes S&P down to 2,033
11:06AM  How Actavis Has Emerged through Mergers and Acquisitions
11:03AM  Biogen Idec: Survey Says at
11:00AM  A Must-See Biotech ETF Chart
09:30AM  The Top-Performing Biotech Stock During a Sizzling First Quarter at TheStreet
Mar-31-15 05:38PM  Strange close in some ETFs Tuesday at CNBC
03:11PM  Biotech -Monthly reversal pattern in play at resistance
12:57PM  Biotech ETFs in Focus after a Choppy Week - ETF News And Commentary
12:30PM  An ETF That can Quiet Biotech Boo Birds
11:30AM  Bankrupt Introgen Seeks Reincarnation IPO in Biotech Bubble at TheStreet
07:53AM  How bubbles are blown: Biotech edition
Mar-30-15 03:07PM  Why Gilead Stock Could Rise
Mar-27-15 02:18PM  S&P Capital IQ: Diversified Health-Care ETFs for Biotech Lovers at
Mar-26-15 05:30PM  Biotech's rough ride over?
12:32PM  What You Need To Know About This Boom: Our Q&A With A Biotech Expert
10:00AM  Sell-Off in Biotech, Semiconductor ETFs: A Nice Entry Point? - ETF News And Commentary
08:17AM  Topping patterns in the hottest of the hot
07:17AM  Biotech Stocks Are Selling Off Just Like 2014 -- and That Might Be a Good Thing at TheStreet
Mar-25-15 05:28PM  Biotech's biggest threat -5.39%
04:16PM  An Ugly Day on Wall Street
02:13PM  Top trades before the closing bell at CNBC
01:02PM  Market selloff: Biggest gainers decline
Mar-24-15 11:26AM  White hot Biotech ETF creates bearish wick at resistance
Mar-23-15 03:37PM  Signs of Froth in the Biotech Sector
12:31PM  Analyst says Biogen has been 'wild-fun,' but it's time to take a break
12:24PM  Are Biotechs the New Dot-coms?
12:21PM  SunTrust Names Eli Lilly, Merck, Bristol-Myers as 'Favorite' Pharma Firms
Mar-20-15 05:06PM  Biggest risk to the biotech boom
04:27PM  Biotech bulls take charge
02:40PM  Triple-Leveraged Biotech ETFs Could be Coming Soon ETF Trends
10:30AM  Direxion Plans Two Triple-Leveraged Biotech ETFs - ETF News And Commentary
10:06AM  Analysts are going crazy for this biotech company after results from an Alzheimer's trial
Mar-19-15 04:57PM  Not So Fast, Mr. Value
02:26PM  Stocks sold off on Thursday except for the one sector people are calling a bubble
Mar-17-15 05:59PM  Biotech, Small-Cap ETFs Stand Out Among March Winners at Investor's Business Daily
10:00AM  3 ETFs for a Green Portfolio on St. Patrick's Day - ETF News And Commentary
Mar-16-15 11:45PM  Biotech is one of the best performing sectors of the decade and its still hitting all-time highs
11:24PM  Biotech Is One Of The Best Performing Sectors Of The Decade, And Its Still Hitting All-Time Highs
09:30AM  Zacks Investment Ideas feature highlights: Biogen, Amgen, SPDR S&P Biotech ETF, BioShares Biotechnology Clinical Trials Fund and ProShares Ultra Nasdaq Biotechnology ETF - Press Releases
Mar-13-15 12:02PM  3 Biotech ETFs Crushing the Market in 2015 - ETF News And Commentary
Mar-12-15 09:25AM  The Biotech Bubble Debate: Solid Science vs. Sky-High Valuations at TheStreet
Mar-11-15 11:11AM  Biotech ETFs Head to Head: XBI Vs. FBT - ETF News And Commentary
Mar-09-15 02:34PM  Three Reasons to Fear Biotech Stocks Right Now at
Mar-04-15 05:30PM  Orexigen soars on drug data
08:44AM  The only 5 investments you need to own at MarketWatch
Feb-27-15 11:19AM  3 ETFs Surging at Start of 2015 - ETF News And Commentary
Feb-25-15 03:06PM  The Best Biotech ETF Isn't Always The Biggest Benzinga
Feb-23-15 05:00PM  Trading tech & biotech: 8 plays on 2 hot sectors
Feb-19-15 05:27PM  Who can beat the 'superbug'?
Feb-09-15 05:30PM  Regulus joins the race to cure Hep C
Feb-05-15 11:30AM  Biotechs Walking a Fine Line
Feb-04-15 05:46PM  Best biotech plays CNBC
12:37PM  Gilead Dislodges a Brick in the Biotech Wall of Worry Yahoo Finance Contributors
Feb-02-15 07:03AM  Biotech Stocks Climb Wall of Worry in January Yahoo Finance Contributors
Jan-30-15 05:13PM  Intercept absolutely a buy: Pro CNBC
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.